Sumatriptan

舒馬曲普坦
Mechanism of action:
Sumatriptan 是一種血清素 5-HT₁B/5-HT₁D 受體促效劑(selective 5-HT₁B/5-HT₁D receptor agonist),屬於翠普登類(triptan)。Sumatriptan 的作用集中於顱內三叉神經與週遭血管系統(trigeminovascular system),刺激顱內(特別是硬腦膜)血管平滑肌上的 5-HT₁B 受體,使顱內血管張力上調並引發血管收縮反應;在三叉神經末梢刺激 5-HT₁D 受體,減少抑鈣基因相關胜肽(calcitonin gene-related peptide)、P 物質(substance P)等促發炎與致痛神經胜肽的釋放,減少神經性發炎與疼痛傳導。
Reference(s):
1. Nikai T et al. (2008). Profound reduction of somatic and visceral pain in mice by intrathecal administration of the anti-migraine drug, sumatriptan. Pain.
2. Ferrari MD et al. (1992). Clinical effects and mechanism of action of sumatriptan in migraine. Clin Neurol Neurosurg.
3. Duquesnoy C et al. (1998). Comparative clinical pharmacokinetics of single doses of sumatriptan following subcutaneous, oral, rectal and intranasal administration. Eur J Pharm Sci.
